Genetics and new approaches to cancer therapy - Commentary

被引：26

作者：

Cavenee, WK ^{[1
]}

机构：

[1] Univ Calif San Diego, Ctr Mol Genet, Dept Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA

[2] Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA

来源：

CARCINOGENESIS | 2002年 / 23卷 / 05期

关键词：

D O I：

10.1093/carcin/23.5.683

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：683 / 686

页数：4

共 34 条

[21] Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway [J].

Prigent, SA ;

Nagane, M ;

Lin, H ;

Huvar, I ;

Boss, GR ;

Feramisco, JR ;

Cavenee, WK ;

Huang, HJS .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (41) :25639-25645

[22]

Rasheed B K, 1999, Curr Opin Oncol, V11, P162

[23] In vitro and in vivo behavior of radiolabeled chimeric anti-EGFRvIII monoclonal antibody: Comparison with its murine parent [J].

Reist, CJ ;

Batra, SK ;

Pegram, CN ;

Bigner, DD ;

Zalutsky, MR .

NUCLEAR MEDICINE AND BIOLOGY, 1997, 24 (07) :639-647

[24]

Reist CJ, 1997, CANCER RES, V57, P1510

[25] Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors [J].

Sampson, JH ;

Crotty, LE ;

Lee, S ;

Archer, GE ;

Ashley, DM ;

Wikstrandt, CJ ;

Hale, LP ;

Small, C ;

Dranoff, G ;

Friedman, AH ;

Friedman, HS ;

Bigner, DD .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (13) :7503-7508

[26]

SCHLEGEL J, 1994, INT J CANCER, V56, P72

[27]

Schmidt M, 1998, INT J CANCER, V75, P878, DOI 10.1002/(SICI)1097-0215(19980316)75:6<878::AID-IJC10>3.3.CO

[28]

2-U

[29]

Tang CK, 2000, CANCER RES, V60, P3081

[30] Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas [J].

Watanabe, K ;

Sato, K ;

Yonekawa, Y ;

Kleihues, P ;

Ohgaki, H .

BRAIN PATHOLOGY, 1996, 6 (03) :217-223

← 1 2 3 4 →